These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


350 related items for PubMed ID: 12355549

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I, Németh A, Bogner B, Pajkos G, Orsós Z, Sándor J, Csejtey A, Faluhelyi Z, Rodler I, Ember I.
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
    Leggett CS, Doll MA, States JC, Hein DW.
    Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
    [Abstract] [Full Text] [Related]

  • 25. Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population.
    Srivastava DS, Mittal RD.
    BMC Urol; 2005 Aug 06; 5():12. PubMed ID: 16083506
    [Abstract] [Full Text] [Related]

  • 26. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
    Majumder M, Ghosh S, Roy B.
    Indian J Med Res; 2012 Oct 06; 136(4):605-13. PubMed ID: 23168701
    [Abstract] [Full Text] [Related]

  • 27. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
    Henning S, Cascorbi I, Münchow B, Jahnke V, Roots I.
    Pharmacogenetics; 1999 Feb 06; 9(1):103-11. PubMed ID: 10208649
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
    Morton LM, Schenk M, Hein DW, Davis S, Zahm SH, Cozen W, Cerhan JR, Hartge P, Welch R, Chanock SJ, Rothman N, Wang SS.
    Pharmacogenet Genomics; 2006 Aug 06; 16(8):537-45. PubMed ID: 16847422
    [Abstract] [Full Text] [Related]

  • 32. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
    Prawan A, Kukongviriyapan V, Tassaneeyakul W, Pairojkul C, Bhudhisawasdi V.
    Eur J Cancer Prev; 2005 Jun 06; 14(3):245-50. PubMed ID: 15901993
    [Abstract] [Full Text] [Related]

  • 33. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC.
    Cancer Res; 1995 Aug 15; 55(16):3537-42. PubMed ID: 7627961
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk.
    Wikman H, Piirilä P, Rosenberg C, Luukkonen R, Kääriä K, Nordman H, Norppa H, Vainio H, Hirvonen A.
    Pharmacogenetics; 2002 Apr 15; 12(3):227-33. PubMed ID: 11927838
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
    Ferguson RJ, Doll MA, Rustan TD, Hein DW.
    Pharmacogenetics; 1996 Feb 15; 6(1):55-66. PubMed ID: 8845861
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.